Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gwent Group is a UK-based manufacturing and technology group focused on biosensor materials, enzyme stabilisation, electrochemical sensors, and related printed electronic materials. The group has historically comprised Gwent Electronic Materials and Applied Enzyme Technology, combining expertise in specialist inks, screen-printed sensor materials, and stabilised enzymes for diagnostic, environmental, and industrial sensor applications. It appears to operate as a commercial products-and-services business rather than a therapeutic drug developer, with quality systems that have included ISO 9001 and ISO 13485 for medical-device-related design and manufacture. Publicly available sources indicate that the broader Gwent businesses were acquired by Sun Chemical/DIC, while the UK legal entity GWENT GROUP LIMITED remains active on Companies House. The company is therefore healthcare-related through diagnostics and biosensor technologies, but not a biotech therapeutics company with a clinical drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gwent Group.